Compare Alnylam Pharmaceuticals, Inc. (ALNY) vs Kingsoft Cloud Holdings Limited (KC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Alnylam Pharmaceuticals, Inc. vs Kingsoft Cloud Holdings Limited — how do they compare? Alnylam Pharmaceuticals, Inc. trades at $288 (market cap $39.89B), while Kingsoft Cloud Holdings Limited trades at $10.39 (market cap $3.25B). The key difference: Alnylam Pharmaceuticals, Inc. is far larger — about 12.3× Kingsoft Cloud Holdings Limited's market cap, and Kingsoft Cloud Holdings Limited is trading nearer its 52-week high, Alnylam Pharmaceuticals, Inc. nearer its low. Which is the better fit depends on your goals.
| ALNY | KC | |
|---|---|---|
Market Cap | $39.89B | $3.25B |
Sector | Health | Technology |
52-Week High | $491.22 | $18.21 |
52-Week Low | $278.09 | $8.58 |
Enterprise Value | $38.15B | $3.56B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Kingsoft Cloud (KC) trades at $10.91, up 4.2% today, with a bullish technical signal and strong analyst support (70% buy ratings). Recent earnings beats and accelerating revenue growth, driven by AI cloud demand, highlight operational momentum, though profitability remains negative. The stock is near resistance at $11, with RSI indicating potential overbought conditions short-term.
The outlook is cautiously optimistic given AI-driven growth potential and positive sentiment, but risks include persistent losses, high capital expenditure, and competitive pressures. Upside depends on margin improvement from AI investments, making KC a speculative growth play with significant execution risk.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia.
Read more on ALNY →About Kingsoft Cloud Holdings Limited
Kingsoft Cloud is a leading independent cloud service provider in China. It offers a comprehensive suite of cloud products and solutions tailored for industries like gaming, video streaming, and financial services.
Read more on KC →
